Mendieta G, Ridker PM, Borlaug BA, Ducharme A, et al. Ziltivekimab in heart failure with preserved and mildly reduced ejection
fraction: rationale and design of the ATHENA and HERMES trials. Eur J Heart Fail 2026 May 10:xuag153. doi: 10.1093.
PMID: 42106986
|